These findings corroborate with earlier reports wherein a positive correlation of ANXA3 with axillary lymphatic metastasis was observed [28–30] and with Zeidan et al. who demonstrated that ANXA3 was a potential therapeutic target for breast cancer [31]. The gene discussed is ANXA3; the disease is metastasis.